Altria beats quarterly estimates on robust nicotine pouch demand

Altria (MO.N) exceeded second-quarter Wall Street estimates, reporting revenue of $5.29 billion, up 0.2% year-over-year, and adjusted earnings of $1.44 per share, primarily driven by a 26.5% surge in shipment volumes for its 'on!' nicotine pouches. This strong performance in alternative products helped offset a 10.2% decline in smokeable tobacco volumes and the earlier halt of its NJOY vape brand, contrasting with a recent slowdown in rival Philip Morris International's ZYN shipments. The company slightly raised its full-year adjusted earnings guidance to $5.35-$5.45 per share, despite recording a $354 million impairment charge related to its Skoal smokeless tobacco trademark.

Analysis

Altria Group (MO) delivered a notable second-quarter performance, exceeding Wall Street estimates with revenue of $5.29 billion, a 0.2% year-over-year increase that contrasted with analyst expectations for a 1.8% decline. This outperformance was primarily fueled by the accelerating growth of its 'on!' nicotine pouches, which saw shipment volumes surge by 26.5%. This robust demand is particularly significant as it comes at a time when rival Philip Morris International reported below-expectation shipments for its market-leading ZYN brand, suggesting Altria may be capturing market share in this critical growth segment. The strength in nicotine pouches successfully offset multiple headwinds, including the continued structural decline in its smokeable tobacco business, where volumes fell 10.2%, and the complete halt of its NJOY vape sales due to a patent dispute. Despite booking a $354 million pre-tax impairment charge on its Skoal smokeless tobacco trademark, management signaled increased confidence by raising the lower end of its full-year adjusted EPS guidance to a new range of $5.35 to $5.45 per share.

Key Decisions for Investors

• Investors should view the 26.5% volume growth in 'on!' nicotine pouches as a significant positive catalyst, especially given the simultaneous report of slowing shipments for Philip Morris's dominant ZYN brand, indicating a potential market share shift.
• It is crucial to monitor the sustainability of the 'on!' segment's growth trajectory, as it currently serves as the main offset to the persistent 10.2% volume decline in the legacy cigarette business and the complete absence of NJOY vape revenue.
• The raised lower-end of the full-year EPS guidance to $5.35 provides a firmer valuation floor, but the $354 million impairment charge on the Skoal brand is a material reminder of the ongoing value erosion in the company's traditional product portfolio.